Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.07.08.602202

On the replicability of diffusion weighted MRI-based brain-behavior models

Abstract

Establishing replicable inter-individual brain-wide associations is key to advancing our understanding of the crucial links between brain structure, function, and behavior, as well as applying this knowledge in clinical contexts. While the replicability and sample size requirements for anatomical and functional MRI-based brain-behavior associations have been extensively discussed recently, systematic replicability assessments are still lacking for diffusion-weighted imaging (DWI), despite it being the dominant non-invasive method to investigate white matter microstructure and structural connectivity. We report results of a comprehensive evaluation of the replicability of various DWI-based multivariate brain-behavior models. This evaluation is based on large-scale data from the Human Connectome Project, including five different DWI-based brain features (from fractional anisotropy to structural connectivity) and 58 different behavioral phenotypes. Our findings show an overall moderate replicability, with 24-31% of phenotypes replicable with sample sizes of fewer than 500. As DWI yields trait-like brain features, we restricted the analysis to trait-like phenotypes, such as cognitive and motor skills, and found much more promising replicability estimates, with 67-75% of these phenotypes replicable with n<500. Contrasting our empirical results to analytical replicability estimates substantiated that the replicability of DWI-based models is primarily a function of the true, unbiased effect size. Our work highlights the potential of DWI to produce replicable brain-behavior associations. However, it shows that achieving replicability with small-to-moderate samples requires stable, reliable and neurobiologically relevant target phenotypes. Our work highlights the potential of DWI to produce replicable brain-behavior associations, but only for stable, reliable and neurobiologically relevant target phenotypes. HIGHLIGHTSO_LIModerate replicability in DWI-based models: Overall replicability of DWI-based brain-behavior associations ranges from 24-31% with sample sizes under 500. C_LIO_LIImproved replicability for trait-like phenotypes: Trait-like phenotypes e.g., cognitive and motor skills exhibit higher replicability estimates of 67-75%, compared to state-like phenotypes such as emotion. C_LIO_LIEffect size as a key factor: Replicability is primarily influenced by the true, unbiased effect size, highlighting the importance of targeting stable and reliable phenotypes. C_LIO_LIPromise of -based multivariate associations: DWI-based brain-behaviour models should focus on phenotypes that display a sufficient temporal stability and test-retest reliability. C_LI

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kotikalapudi, R., Kincses, B., Gallitto, G., Englert, R., Hoffschlag, K., Li, J., Bingel, U., Spisak, T.. 2024-07-11. On the replicability of diffusion weighted MRI-based brain-behavior models. https://doi.org/10.1101/2024.07.08.602202

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗